Natriuretic peptides in patients with aortic stenosis

Area of Science:

• Cardiology
• Biomarkers
• Cardiac Physiology

Background:

• Atrial natriuretic peptide (ANP) primarily originates from cardiac atria, while brain natriuretic peptide (BNP) is mainly produced in the ventricles.
• The comparative significance of ANP and BNP as indicators of cardiac function and myocardial hypertrophy requires further clarification.
• This study investigates circulating BNP, ANP, and their N-terminal propeptides (NT-proBNP, NT-proANP) as markers for left ventricular hypertrophy and elevated atrial pressure in patients with aortic stenosis.

Purpose of the Study:

• To evaluate the efficacy of BNP, NT-proBNP, ANP, and NT-proANP as biomarkers for left ventricular hypertrophy and increased atrial pressure.
• To determine the diagnostic performance of these natriuretic peptides in patients diagnosed with aortic stenosis.
• To assess the potential of these peptides in early detection and staging of aortic stenosis.

Main Methods:

• Plasma concentrations of BNP, NT-proBNP, ANP, and NT-proANP were quantified using radioimmunoassay in 67 patients with aortic stenosis.
• Cardiac catheterization and echocardiography data were utilized to correlate peptide levels with cardiac measurements.
• Receiver operating characteristic (ROC) curve analysis was employed to assess the diagnostic accuracy of each peptide.

Main Results:

• BNP and NT-proBNP demonstrated superior performance in detecting increased left ventricular mass compared to ANP and NT-proANP.
• NT-proANP was identified as the most effective marker for detecting elevated left atrial pressure.
• NT-proBNP levels were significantly elevated in cases of mild left ventricular hypertrophy (LV mass index 78–139 g/m²), while NT-proANP elevations were observed at higher LV mass indices (141–180 g/m²).

Conclusions:

• Circulating BNP and NT-proBNP can serve as early diagnostic markers for left ventricular hypertrophy.
• ANP and NT-proANP effectively indicate an increase in left atrial pressure.
• Combined and repeated measurements of natriuretic peptides may offer valuable diagnostic insights for assessing the progression of aortic stenosis.